Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stromal vascular fraction injection with endoscopic urethrotomy for recurrent bulbar urethral stenosis
2022-002175-11Phase 2Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous adipose-derived stromal vascular fraction in Urethral stenosis (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Safety of autologous stromal vascular fraction injection added to endoscopic urethrotomy. Started Jun 2024; status: active.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
Urethral stenosis
Beyond the preview
Go deeper on 2022-002175-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002175-11.